Clinical Trial Update: Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update examining whether liraglutide reduces endoplasmic reticulum stress in obese patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Temple University | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN